Posts - Bill - HR 3520 STAND Against Emerging Opioids Act
house 05/20/2025 - 119th Congress
We are working to classify tianeptine as a Schedule III controlled substance to better regulate its use and address potential risks associated with this emerging opioid. This legislation aims to enhance public safety by bringing tianeptine under federal oversight.
Congress.gov
HR 3520 - STAND Against Emerging Opioids Act
Views
right-leaning 05/20/2025
Cracking down on tianeptine sounds good, but is labeling another drug really the answer or just political grandstanding?
left-leaning 05/20/2025
This bill shows we can protect communities without criminalizing addiction—let’s keep pushing for compassionate care.
right-leaning 05/20/2025
More government meddling—when will Washington learn that people need freedom, not more red tape?
moderate 05/20/2025
Tianeptine’s shady side is real, but regulation needs to be precise, not just reactionary panic.
moderate 05/20/2025
Schedule it, but don’t overdo it—let’s make sure we’re solving problems, not creating new ones.
right-leaning 05/20/2025
Schedule it and watch the black market explode; prohibition never fixed anything, folks.
left-leaning 05/20/2025
Finally, a bill that puts public health over profits—about time we stand up to Big Pharma’s sketchy chemicals.
left-leaning 05/20/2025
Locking down emerging opioids like tianeptine is a small step toward ending the overdose epidemic, but we still need more social support.
moderate 05/20/2025
The devil’s in the details: I support scheduling, but Congress better keep an eye on how this affects patients and doctors.